Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stem Cells Generated with Oct4 Cannot Form a Complete Organism

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Researchers at the Max Planck Institute for Molecular Biomedicine have demonstrated that an egg cell does not require Oct4 to develop into a complete organism.

Somatic cells have already assumed specific tasks through differentiation, but they can be reprogrammed into “all rounders”: by using only four factors, a specialised somatic cell can thus regain its ability to form any type of cell (pluripotency). One of those factors is Oct4. Scientists from Hans Schöler’s team at the Max Planck Institute for Molecular Biomedicine in Münster have now been able to demonstrate that an egg cell does not require Oct4 to develop into a complete organism (totipotency). This means that reprogramming cells to make them pluripotent by using the four factors, including Oct4, and reprogramming an egg cell through fertilisation or cloning are significantly different processes.

For quite some time, scientists have ascribed Oct4 an important role in early embryonic development—after all, the protein is present in the egg cell. To study the role of Oct4 in the transition from totipotency to pluripotency, the Max Planck researchers had to deactivate Oct4 in the egg cell. To do this, they used a genetically modified mouse model in which the protein Oct4 was eliminated only in the egg cells. “Contrary to the established premise that Oct4 is crucial for the early embryonic stages of development, the mice without Oct4 were as fertile as those with Oct4,” according to Guangming Wu, first author of the study. “In other words, it was still possible to activate the totipotency of the fertilised egg cells, as in normal fertilisation,” he adds.

Another established assumption was that the fate of the cells in the early embryo is decided by the balance between the protein Oct4 and its antagonist, the protein Cdx2. According to this assumption, Oct4 would turn the cells into embryoblast cells, from which the foetus would later form. Cdx2, on the other hand, would transform the cells into trophoblasts, a subsequent part of the placenta. Consequently, without Oct4, there would be an empty trophoblast envelope. The researchers found that despite the elimination of Oct4, an embryo with an embryoblast formed. However, the cells quickly lost their pluripotency. Wu explains, “There must therefore be other factors that determine the fate of the cells in the early embryo. Identifying the factors that are decisive for embryonic cloning and pluripotency will be the subject of future research.”

In 2009, Hans Schöler and his team demonstrated that certain somatic cells could be reprogrammed into stem cells by using Oct4 alone. Scientists hope that they will be able to use such induced pluripotent stem cells to better study diseases without requiring human embryos to harvest stem cells. “Our study shows that cloning leads to totipotency with or without Oct4, while reprogramming cells for pluripotency is not possible without Oct4,” Hans Schöler explains. “The two types of reprogramming are fundamentally different. This is also an important finding with regard to the Embryo Protection Act. If these two processes were to involve the same mechanisms, there could be totipotent cells among the induced pluripotent stem cells generated with Oct4, in which case the Embryo Protection Act would apply.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!